Cytosorbents (CTSO) Total Non-Current Liabilities (2010 - 2017)
Cytosorbents' (CTSO) quarterly Total Non-Current Liabilities came in at $13.1 million in Q2 2017, up 87.33% YoY from $7.0 million in Q2 2016, and up 60.14% on a QoQ basis from $8.2 million in Q1 2017.
Cytosorbents (CTSO) Total Non-Current Liabilities (2010 - 2017) Analysis & Trends
Cytosorbents (CTSO) has 6 years of Total Non-Current Liabilities data on file, last reported at $13.1 million in Q2 2017.
- Quarterly Total Non-Current Liabilities rose 87.33% year-over-year to $13.1 million in Q2 2017, while the trailing twelve-month figure through Jun 2017 was $13.1 million (up 87.33% YoY) and the FY2016 annual result came in at $6.5 million, up 364.95% from the prior year.
- Total Non-Current Liabilities rose to $13.1 million in Q2 2017, from $8.2 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $13.1 million in Q2 2017 to a low of $1.4 million in Q4 2015.
- A 4-year average of $7.1 million and a median of $7.1 million in 2016 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2015 — Total Non-Current Liabilities sank 74.35% — and 2016, when it surged 364.95%.
- Tracing CTSO's Total Non-Current Liabilities over 4 years: stood at $5.5 million in 2014, then slumped by 74.35% to $1.4 million in 2015, then surged by 364.95% to $6.5 million in 2016, then soared by 100.53% to $13.1 million in 2017.
- The last three Total Non-Current Liabilities figures came in at $13.1 million (Q2 2017), $8.2 million (Q1 2017), and $6.5 million (Q4 2016), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Cytosorbents | 19.47 Mn | 15.06 Mn | 7.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 13.12 Mn |
| Mar 31, 2017 | 8.20 Mn |
| Dec 31, 2016 | 6.54 Mn |
| Sep 30, 2016 | 7.18 Mn |
| Jun 30, 2016 | 7.01 Mn |
| Mar 31, 2016 | 7.89 Mn |
| Dec 31, 2015 | 1.41 Mn |
| Dec 31, 2014 | 5.49 Mn |
| Dec 31, 2011 | 276,250.00 |
| Sep 30, 2011 | 224,818.00 |
| Jun 30, 2011 | 526,554.00 |
| Dec 31, 2010 | 1.08 Mn |